470 reports of this reaction
3.2% of all LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS reports
#3 most reported adverse reaction
DIARRHOEA is the #3 most commonly reported adverse reaction for LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, manufactured by Cipla USA Inc.. There are 470 FDA adverse event reports linking LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS to DIARRHOEA. This represents approximately 3.2% of all 14,515 adverse event reports for this drug.
Patients taking LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is moderately reported among LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS users, representing a notable but not dominant share of adverse events.
In addition to diarrhoea, the following adverse reactions have been reported for LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 470 FDA reports for LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 3.2% of all adverse event reports for LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, making it one of the most commonly reported side effect.
If you experience diarrhoea while taking LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.